Costing infectious disease outbreaks for economic evaluation: a review for hepatitis A.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2009 AND VI 27 AND IP 5
Results: 15
1
2
Utility assessment in patients with mental disorders: validity and discriminative ability of the time trade-off method.
- Published in:
- 2009
- By:
- Publication type:
- journal article
3
The cost of dementia in Europe: a review of the evidence, and methodological considerations.
- Published in:
- 2009
- By:
- Publication type:
- journal article
4
The cost and impact of health conditions on presenteeism to employers: a review of the literature.
- Published in:
- 2009
- By:
- Publication type:
- journal article
5
The future costs, risks and rewards of drug development: the economics of pharmacogenomics.
- Published in:
- 2009
- By:
- Publication type:
- journal article
6
Utility Assessment in Patients with Mental Disorders.
- Published in:
- PharmacoEconomics, 2009, v. 27, n. 5, p. 405, doi. 10.2165/00019053-200927050-00005
- By:
- Publication type:
- Article
7
Update of Recent Reforms in Germany to Enhance the Quality and Efficiency of Prescribing of Proton Pump Inhibitors and Lipid-Lowering Drugs.
- Published in:
- PharmacoEconomics, 2009, v. 27, n. 5, p. 435, doi. 10.2165/00019053-200927050-00010
- By:
- Publication type:
- Article
8
The Future Costs, Risks and Rewards of Drug Development.
- Published in:
- PharmacoEconomics, 2009, v. 27, n. 5, p. 355, doi. 10.2165/00019053-200927050-00001
- By:
- Publication type:
- Article
9
The Cost of Dementia in Europe.
- Published in:
- PharmacoEconomics, 2009, v. 27, n. 5, p. 391, doi. 10.2165/00019053-200927050-00004
- By:
- Publication type:
- Article
10
The Cost and Impact of Health Conditions on Presenteeism to Employers.
- Published in:
- PharmacoEconomics, 2009, v. 27, n. 5, p. 365, doi. 10.2165/00019053-200927050-00002
- By:
- Publication type:
- Article
11
The Author's Reply.
- Published in:
- 2009
- By:
- Publication type:
- Letter
12
Pharmaceutical Risk-Sharing Agreements.
- Published in:
- PharmacoEconomics, 2009, v. 27, n. 5, p. 431, doi. 10.2165/00019053-200927050-00007
- By:
- Publication type:
- Article
13
Outcomes Associated with Initial versus Later Vancomycin Use in Patients with Complicated Skin and Skin-Structure Infections.
- Published in:
- PharmacoEconomics, 2009, v. 27, n. 5, p. 421, doi. 10.2165/00019053-200927050-00006
- By:
- Publication type:
- Article
14
Costing Infectious Disease Outbreaks for Economic Evaluation.
- Published in:
- PharmacoEconomics, 2009, v. 27, n. 5, p. 379, doi. 10.2165/00019053-200927050-00003
- By:
- Publication type:
- Article
15
Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium.
- Published in:
- 2009
- By:
- Publication type:
- Letter